A real-world analysis of survival and cost-effectiveness of sintilimab plus bevacizumab biosimilar regimen in patients with advanced hepatocellular carcinoma
Xiang-Hua Zeng, Yingxin Jia, Hongmei Chen, Qinli Luo +4 more
2023Journal of Cancer Research and Clinical Oncology10 citations Open access
Semantic Scholar

